Concepedia
Statistics
Publications
10
Citations
920
H-Index
Active since
1996
Affiliations
Ben-Gurion University of the Negev(Current)
NGM Biopharmaceuticals (United States)
University of California, San Francisco
Teva Pharmaceuticals (Israel)
Weizmann Institute of Science
Rom E. Eliaz is an author at Ben-Gurion University of the Negev specializing in drug delivery, pharmacology, and pharmacy.
Publications per year
1996–2016
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Rom E. Eliaz, Francis C. Szoka · PubMed · 2001 · 330 citations
Pharmacy, Oncology, Pharmacology +15
Characterization of a polymeric PLGA-injectable implant delivery system for the controlled release of proteins
Rom E. Eliaz, Joseph Kost · Journal of Biomedical Materials Research · 2000 · 160 citations
Pharmacy, Biomedical Engineering, Pharmaceutics +17
Determination and Modeling of Kinetics of Cancer Cell Killing by Doxorubicin and Doxorubicin Encapsulated in Targeted Liposomes
Rom E. Eliaz, Shlomo Nir, Cornelia Marty et al. · Cancer Research · 2004 · 152 citations
Medicine, Cancer Biology, Pharmacology +14
Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson’s disease: a pharmacogenetic study
Mario Masellis, S.Karen Collinson, Natalie Freeman et al. · Brain · 2016 · 62 citations · Full text
Medicine, Genetics, Pharmacology +17
Robust and prolonged gene expression from injectable polymeric implants
Rom E. Eliaz, Francis C. Szoka · Gene Therapy · 2002 · 55 citations
Life Sciences, Bioengineering, Biotechnology +14
1–5 of 10